D-Biotin Prices & Trade in Ecuador — Market Overview 2026
Parent Product
Vitamin B7 (Biotin)
HS Code
293629
Last Updated
2026-09-27
Key takeaways for search and sourcing teams
- Latest reference year in this page dataset is 2024.
- Page data last updated on 2026-09-27.
D-Biotin Export Supplier Intelligence, Price Trends, and Trade Flows in Ecuador
Use Supply Chain Intelligence company profiles and analytics to validate D-Biotin exporter coverage, partner quality, and route priorities in Ecuador.
Annual Export Value, Volume, and Supplier Market Size for D-Biotin in Ecuador (HS Code 293629)
Analyze 1 years of D-Biotin export volume and value in Ecuador to evaluate supplier market growth, seasonality, and trade volatility.
| Year | Volume | Value |
|---|---|---|
| 2024 | 2,651 | 31,489 USD |
Top Destination Markets for D-Biotin Exports from Ecuador (HS Code 293629) in 2024
For 2024, compare export volume and value across the top 4 destination countries for D-Biotin exports from Ecuador.
| Rank | Country | Volume | Value |
|---|---|---|---|
| 1 | Peru | 1,649.6 | 24,030.05 USD |
| 2 | United States | 960 | 3,782.4 USD |
| 3 | Colombia | 40 | 2,385.6 USD |
| 4 | Spain | 1.8 | 1,290.5 USD |
Sourcing diagnosis
Could you be importing D-Biotin from Ecuador yourself?
Just tell us your spec and the volume you need. We'll check whether it's actually sourceable, and which origins and suppliers fit.
Free diagnosis, no account required.
Export diagnosis
Your D-Biotin — could it sell to these buyers in Ecuador?
Just tell us what you make. We'll see whether you're ready to export today and which markets suit your offer.
Free diagnosis, no account required.
Price data
Which D-Biotin prices in Ecuador do you need?
We'll open up the full price history and competitor benchmarks. Just tell us which numbers you need and we'll walk you through them.
Classification
Product TypeProcessed Food
Product FormDietary supplement (solid oral dose: capsule/tablet)
Industry PositionFinished nutraceutical / consumer health product
Market
Biotin supplements marketed in Ecuador fall under the regulatory category of “suplementos alimenticios” and require an ARCSA Notificación Sanitaria prior to importation, distribution, and commercialization. The compliance pathway is documentation-heavy, typically requiring a label/rotulado project in Spanish plus technical support files (manufacturing process description, lot-code interpretation, and product specifications) submitted through the VUE workflow used for processed foods. Ecuador functions primarily as an import-dependent consumer market for finished supplements, with market access shaped by importer registration and customs formalities under SENAE. Therapeutic disease-treatment claims are not accepted for supplement inscription, making labeling and claims discipline a recurring market-entry constraint.
Market RoleImport-dependent consumer market (Net importer)
Domestic RoleDomestic distribution and retail of authorized (notified) supplements via regulated importers and local wholesalers
Specification
Physical Attributes
- Common presentations include solid oral formats such as capsules or tablets (among other allowed forms for suplementos alimenticios).
Compositional Metrics
- Declared biotin content per serving/portion must align with the submitted technical documentation and the approved label/rotulado under Ecuador’s processed-food labeling framework.
Packaging
- Primary packaging must support product stability and carry lot coding to enable traceability; label/rotulado is assessed against RTE INEN 022 and related INEN labeling norms referenced by ARCSA.
Supply Chain
Value Chain
- Overseas GMP/BPM manufacturer → Ecuador importer/titular of ARCSA Notificación Sanitaria → customs clearance (DAI/ECUAPASS) → warehousing/distribution → retail (pharmacies/health stores) → consumer
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighAbsence of ARCSA Notificación Sanitaria (or inconsistencies between the submitted file and the marketed label/presentation) can block importation and commercialization of biotin supplements in Ecuador and expose shipments/stock to enforcement actions.Obtain ARCSA Notificación Sanitaria for each presentation/formulation before shipment; keep label, formulation, and technical dossier fully consistent and controlled under document versioning.
Labeling And Claims MediumLabels that imply therapeutic disease prevention/treatment/cure, or otherwise fail Ecuador’s processed-food labeling/rotulado requirements, can cause rejection or corrective actions during inscription or post-market controls.Run a pre-submission label review against RTE INEN 022, INEN 1334 series, and ARCSA supplement inscription guidance; restrict claims to permitted nutrition/health representations.
Food Safety MediumSupplement specifications may be scrutinized for contaminants and quality parameters (e.g., heavy metals, aflatoxins, microbiological limits) as referenced in Ecuador’s technical norms for supplements, creating compliance risk if supplier quality systems are weak.Require a qualified supplier QA program with routine COAs and periodic third-party testing aligned to applicable INEN/ARCSA expectations; maintain retained samples for post-market control.
Formulation Safety MediumARCSA guidance restricts supplements from containing certain high-risk pharmacological or doping-related substances; nonconforming formulations can trigger denial or enforcement even if the label is otherwise compliant.Perform ingredient-screening against ARCSA supplement rules and maintain an excipient/active ingredient compliance matrix; require supplier attestations and verified specifications.
Documentation Gap MediumForeign legal certificates and supporting documents may require official translation (Spanish or English per ARCSA guidance); missing or inconsistent documents can delay authorization and customs release.Create a standardized Ecuador dossier checklist (legal + technical); pre-arrange certified translations and ensure all submitted data matches invoices, labels, and product specs.
Standards
- BPM (Buenas Prácticas de Manufactura) / GMP alignment for supplement manufacturing lines (relevant to ARCSA homologation/authorization workflows)
FAQ
What authorization is required to import and sell a biotin supplement in Ecuador?A biotin dietary supplement must obtain an ARCSA Notificación Sanitaria before it can be imported, stored, distributed, or commercialized in Ecuador. ARCSA processes supplements through the VUE workflow used for processed foods and reviews the label/rotulado and supporting technical documentation as part of the inscription process.
Can a biotin supplement label claim it treats or cures a disease in Ecuador?No. ARCSA guidance for supplement inscription does not accept labels that attribute preventive or therapeutic actions to relieve, treat, or cure a disease. Claims must stay within the permitted labeling framework for processed foods and supplements.
What documents are commonly needed for ARCSA notification and Ecuador customs clearance for supplements?For ARCSA notification, common dossier elements include a Spanish label/rotulado project, a manufacturing process description (or flow diagram), a lot-code interpretation for traceability, and product specifications. For customs clearance under SENAE, importers typically submit the DAI and retain/attach core trade documents such as the commercial invoice, transport document, and certificate of origin when applicable, plus any regulator-required prior-control documents.
Sources
Other D-Biotin Country Markets for Supplier, Export, and Price Comparison from Ecuador
Compare D-Biotin supplier coverage, trade flows, and price benchmarks across countries related to Ecuador.
Export & sourcing diagnosis
D-Biotin in Ecuador — are you buying, or selling?
Either way it's a few questions. We'll come back with where you could buy it, or who you could sell it to.
Free diagnosis, no account required.
Related D-Biotin Product Categories
Browse parent, sub, derived, and raw-material product market pages related to D-Biotin.
Parent product: Vitamin B7 (Biotin)
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.